|
TMEM50A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.4251004516791E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.89441820406E-12 |
| Normal-vs-Stage2 |
2.036000E-02 |
| Normal-vs-Stage3 |
6.202300E-04 |
| Normal-vs-Stage4 |
1.491890E-02 |
| Stage1-vs-Stage2 |
6.327700E-02 |
| Stage1-vs-Stage3 |
1.738450E-02 |
| Stage1-vs-Stage4 |
1.289620E-02 |
| Stage2-vs-Stage3 |
9.268400E-01 |
| Stage2-vs-Stage4 |
7.144400E-01 |
| Stage3-vs-Stage4 |
5.876400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.85339998693257E-09 |
| Normal-vs-AfricanAmerican |
7.139500E-03 |
| Normal-vs-Asian |
2.028900E-04 |
| Caucasian-vs-AfricanAmerican |
9.436200E-01 |
| Caucasian-vs-Asian |
9.550400E-01 |
| AfricanAmerican-vs-Asian |
9.789400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.93619999927708E-08 |
| Normal-vs-Female |
5.94250004759544E-09 |
| Male-vs-Female |
4.659200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.00683913931243E-12 |
| Normal-vs-Age(41-60Yrs) |
3.36170000003744E-06 |
| Normal-vs-Age(61-80Yrs) |
1.763790E-02 |
| Normal-vs-Age(81-100Yrs) |
1.179550E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.163400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.834410E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.714200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.712200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.675800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.022960E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.485810E-01 |
| Classical-VS-Follicular |
6.896000E-01 |
| Classical-VS-Other |
7.558400E-01 |
| Classical-VS-Normal |
1.53720036699667E-10 |
| Tall-VS-Follicular |
3.690800E-01 |
| Tall-VS-Other |
2.915200E-01 |
| Tall-VS-Normal |
5.324900E-03 |
| Follicular-VS-Other |
7.454600E-01 |
| Follicular-VS-Normal |
4.161000E-04 |
| Other-VS-Normal |
6.475900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.79929999963602E-07 |
| Normal-vs-N1 |
2.193700E-04 |
| N0-vs-N1 |
8.751600E-01 |
|
|
